The present invention discloses a method for producing cannabis products comprising steps of providing preselected plant parts or whole plant; optionally drying, grinding and/or extracting the plant to provide a first extract; obtaining a pharmaceutical product performing the following cyclic algorithm during or after the previous step: heating the plant/extract to specific temperature range, and collecting vaporized and/or particularized material into fractions; separating the fractions into sub-fractions characterized by particle size; rendering the separated material into a storable intermediate comprising sub-fractions characterized by particle size sufficient to passively cross the BBB; formulating the storable intermediate suitable for administration; wherein at least one of the steps of separating and rendering in the form of a storable intermediate comprise steps of reducing the volume of the collected material; further wherein the steps of reducing the volume comprise steps of water capture of water-soluble particles, and optionally of cycling through a filter membrane.

A method for producing cannabinoid-containing crystals includes providing a CBGA-containing plant material that includes at least 2% CBGA by dry weight. The CBGA-containing plant material is exposed to a fluid in a supercritical state to extract components of the CBGA-containing plant material. A fraction of the extracted components is coalesced. The coalesced fraction of the extracted components includes cannabinoid-containing crystals containing at least one of CBGA and a cannabinoid derivative of CBGA from the carbon dioxide.

Provided herein is a method of obtaining an extract from a plant biomass as well as an extract obtained from the method. Also provided is a pharmaceutical product, ODF, nutraceutical product, and/or edible product, that includes the extract and one or more excipients. Also provided is a method that includes orally administering the extract (or pharmaceutical product, ODF, nutraceutical product, and/or edible product, that includes the extract).

This invention provides a strengthening and tumor eliminating traditional Chinese medicine composition, its preparation method and application, which specifically relate to the technical field of the treatment of intermediate and advanced stage and postoperative malignant tumor, wherein the strengthening and tumor eliminating traditional Chinese medicine composition comprises: 8-30 parts of Radix codonopsis, 5-30 parts of Rhizoma atractylodis Macrocephalae, 5-30 parts of Poria cocos, 5-30 parts of Pseudobulb of Appendiculate cremastra, 5-30 parts of Scutellaria barbata, 5-30 parts of Sarcandra glabra, 3-30 parts of peach kernel, 2-30 parts of Ligustrum lucidum, 5-30 parts of Eclipta and 1-20 parts of licorice. This invention also provides a preparation method of the described strengthening and tumor eliminating traditional Chinese medicine composition.

A composition is provided for promoting skeletal muscle oxidative muscle fiber generation. The composition comprises a Lycium barbarum water extract. The Lycium barbarum extract comprises polysaccharide, Lycium barbarum flavone, carotenoid, polyphenol, and Lycium barbarum pigment. The composition may further comprise one or more pharmaceutically acceptable excipients selected from such as a solvent, a co-solvent, an emulsifier, a preservative, a buffer, a protein powder, or a combination thereof. The composition may be used as medicine, functional product, or food supplement.

A solubilized steviol glycoside composition including one or more steviol glycosides and one or more steviol glycoside solubility enhancers can be used as a sweetener composition to sweeten other compositions (sweetenable compositions) such as foods, beverages, medicines, oral hygiene compositions, pharmaceuticals, nutraceuticals, and the like.

The present disclosure is directed to cannabinoids infused coffee beans, nuts, and seeds consumables and methods of producing the cannabinoid infused consumables. The consumables are infused in an overall two-step process, in which cannabinoids from a Cannabis species are first infused into coconut oil, which in turn is used to infuse a consumable of choice with cannabinoids to generate the cannabinoids infused consumables.

The present disclosure is directed to cannabinoids infused consumables and non-consumables and methods of producing the cannabinoid infused consumables and non-consumables. The consumables are infused in an overall two-step process, in which cannabinoids from a Cannabis species are first infused into coconut oil, which in turn is used to infuse a food or beverage of choice with cannabinoids to generate the cannabinoids infused consumables. The non-consumables are produced by adding a cannabinoids infused oil to the non-consumables.

A method for making a caffeoylquinic composition from a botanical source is disclosed. The method may include chromatographing an extract of biomass on an ion exchange stationary phase and obtaining an eluent comprising a caffeoylquinic composition. The biomass may be stevia or yerba mate, for example. The caffeoylquinic composition includes one or more of monocaffeoylquinic acid, dicaffeoylquinic acid, and salts of the foregoing.

The present disclosure relates to a herbo-lipid composition for alleviating symptoms related to inflammation resulting into improved quality of life. The herbo-lipid composition comprises an extract of petals and stalks of Padmak, an extract of whole Durva plant, and decoction of roots of Ananta, which are processed in cow's ghee. The herbo-lipid composition of the present disclosure can be used internally for alleviating symptoms of inflammation mainly in erythematous skin rash. Its topical application is also beneficial in radiotherapy induced adverse effects like burning micturition, burning in vagina, dysuria, diarrhea and pain in lower abdomen in cervical cancer patient and stomatitis, and local burning in oral cancer patients. The composition also helps in reducing radiotherapy and chemotherapy induced adverse effects in various types of cancers when given orally.